Aspire Biopharma Holdings (ASBP) EPS (Basic) (2022 - 2026)
Aspire Biopharma Holdings' (ASBP) quarterly EPS (Basic) came in at -$20.57 in Q1 2026, up 95.93% year-on-year from -$10.5 in Q1 2025, and up 87.32% on a QoQ basis from -$162.2 in Q4 2025.
Aspire Biopharma Holdings (ASBP) EPS (Basic) (2022 - 2026) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has 5 years of EPS (Basic) data on file, last reported at -$20.57 in Q1 2026.
- On a quarterly basis, EPS (Basic) rose 95.93% year-over-year to -$20.57 in Q1 2026; TTM through Mar 2026 was -$88.91, a 83.82% increase from a year earlier, with the FY2025 full-year figure at -$388.1, up 28.81% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$20.57, up from -$162.2 in the prior quarter.
- Over the last five years, EPS (Basic) for ASBP reached as high as $72.85 in Q2 2023 and fell as low as -$504.87 in Q1 2025.
- Historically, EPS (Basic) has averaged -$50.57 across 5 years, with a median of -$7.41 in 2024.
- Across the five-year window, EPS (Basic) jumped 5970.52% in 2023 and plunged 576.58% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at -$4.4 in 2022, then decreased by 23.03% to -$5.42 in 2023, then sank by 377.96% to -$25.9 in 2024, then sank by 526.24% to -$162.2 in 2025, then surged by 87.32% to -$20.57 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$20.57 in Q1 2026, -$162.2 in Q4 2025, and -$63.62 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Aspire Biopharma Holdings | 1.21 Mn | -619,284.29 | 5,750.00 | -20.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.57 |
| Dec 31, 2025 | -162.20 |
| Sep 30, 2025 | -63.62 |
| Mar 31, 2025 | -504.87 |
| Dec 31, 2024 | -25.90 |
| Sep 30, 2024 | -9.40 |
| Jun 30, 2024 | -29.94 |
| Mar 31, 2024 | -122.65 |
| Dec 31, 2023 | -5.42 |
| Sep 30, 2023 | -3.44 |
| Jun 30, 2023 | 72.85 |
| Mar 31, 2023 | 28.56 |
| Dec 31, 2022 | -4.40 |
| Sep 30, 2022 | 42.84 |
| Jun 30, 2022 | 1.20 |
| Mar 31, 2022 | -2.09 |